These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24602272)

  • 1. Stability of 1% voriconazole solution in a constant-rate infusion pump for topical ocular delivery to horses.
    Smith KM; Maxwell L; Gull T; Payton ME; Gilmour MA
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():82-9. PubMed ID: 24602272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of six cases of equine corneal stromal abscessation with intracorneal injection of 5% voriconazole solution.
    Smith KM; Pucket JD; Gilmour MA
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():179-85. PubMed ID: 24387183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of systemic voriconazole in equine keratomycosis based on pharmacokinetic-pharmacodynamic analysis of tear fluid following oral administration.
    Tamura N; Okano A; Kuroda T; Niwa H; Kusano K; Matsuda Y; Fukuda K; Mita H; Nagata S
    Vet Ophthalmol; 2020 Jul; 23(4):640-647. PubMed ID: 32383526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constant rate infusion for topical ocular delivery in horses: a pilot study.
    Myrna KE; Herring IP
    Vet Ophthalmol; 2006; 9(1):1-5. PubMed ID: 16409238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of extemporaneously prepared voriconazole ophthalmic solution.
    Al-Badriyeh D; Li J; Stewart K; Kong DC; Leung L; Davies GE; Fullinfaw R
    Am J Health Syst Pharm; 2009 Aug; 66(16):1478-83. PubMed ID: 19667005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of frozen 1% voriconazole ophthalmic solution.
    Amorós-Reboredo P; Bastida-Fernandez C; Guerrero-Molina L; Soy-Muner D; López-Cabezas C
    Am J Health Syst Pharm; 2015 Mar; 72(6):479-82. PubMed ID: 25736943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures.
    Nguyen KQ; Hawkins MG; Taylor IT; Wiebe VJ; Tell LA
    Am J Vet Res; 2009 Jul; 70(7):908-14. PubMed ID: 19566477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
    Pearce JW; Giuliano EA; Moore CP
    Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
    Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC
    Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of ceftazidime (with arginine) and of cefuroxime sodium in infusion-pump reservoirs.
    Stiles ML; Allen LV; Fox JL
    Am J Hosp Pharm; 1992 Nov; 49(11):2761-4. PubMed ID: 1471642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of ondansetron hydrochloride in portable infusion-pump reservoirs.
    Stiles ML; Allen LV; Fox JL
    Am J Hosp Pharm; 1992 Jun; 49(6):1471-3. PubMed ID: 1388331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial.
    André P; Cisternino S; Chiadmi F; Toledano A; Schlatter J; Fain O; Fontan JE
    Ann Pharmacother; 2005 Sep; 39(9):1462-6. PubMed ID: 15985470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of frozen 1% voriconazole eye-drops in both glass and innovative containers.
    Roche M; Lannoy D; Bourdon F; Danel C; Labalette P; Berneron C; Simon N; Odou P
    Eur J Pharm Sci; 2020 Jan; 141():105102. PubMed ID: 31655210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal Therapy in Equine Ocular Mycotic Infections.
    Ledbetter EC
    Vet Clin North Am Equine Pract; 2017 Dec; 33(3):583-605. PubMed ID: 28958862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal stromal abscessation in two horses treated with intracorneal and subconjunctival injection of 1% voriconazole solution.
    Tsujita H; Plummer CE
    Vet Ophthalmol; 2013 Nov; 16(6):451-8. PubMed ID: 23228013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratomycosis in a dog treated with topical 1% voriconazole solution.
    Grundon RA; O'Reilly A; Muhlnickel C; Hardman C; Stanley RG
    Vet Ophthalmol; 2010 Sep; 13(5):331-5. PubMed ID: 20840112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Sustained-Release Voriconazole-Containing Thermogel for Subconjunctival Injection in Horses.
    Cuming RS; Abarca EM; Duran S; Wooldridge AA; Stewart AJ; Ravis W; Babu RJ; Lin YJ; Hathcock T
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2746-2754. PubMed ID: 28549089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of morphine sulfate in portable pump reservoirs during storage and simulated administration.
    Stiles ML; Tu YH; Allen LV
    Am J Hosp Pharm; 1989 Jul; 46(7):1404-7. PubMed ID: 2757049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of atenolol in an extemporaneously compounded oral liquid.
    Garner SS; Wiest DB; Reynolds ER
    Am J Hosp Pharm; 1994 Feb; 51(4):508-11. PubMed ID: 8017418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.